Indeed, arthritis severity was markedly attenuated in IL-18 knock-out (KO) mice (18), as well as by the administration of neutralizing anti-IL-18 antibodies and recombinant human IL-18BP (19). This evidence concerns the gene IL18BP and arthritic joint disease.